Oxford University Press, Nephrology Dialysis Transplantation, 2(30), p. 310-320, 2014
DOI: 10.1093/ndt/gfu293
Full text: Download
Diabetes is the leading cause of end-stage kidney disease (ESKD). Because of conflicting results in observational studies, it is still subject to debate whether in diabetic patients the dialysis modality selected as first treatment (haemodialysis or peritoneal dialysis) may have a major impact on outcomes. We therefore aimed at performing a systematic review of the available evidence.